Stryker Corporation (BMP-7 Assets) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Stryker Corporation (BMP-7 Assets) General Information

Description

Developer of reconstructive bone protein elements. The company is engaged in developing bone morphogenetic protein-7 for the treatment of osteoarthritis, chronic kidney diseases and other fibrosis conditions, lupus, and obesity.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Michigan, ND
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Stryker Corporation (BMP-7 Assets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Stryker Corporation (BMP-7 Assets)‘s full profile, request access.

Request a free trial

Stryker Corporation (BMP-7 Assets) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Stryker Corporation (BMP-7 Assets)‘s full profile, request access.

Request a free trial